{
    "clinical_study": {
        "@rank": "166450", 
        "arm_group": [
            {
                "arm_group_label": "Partial seizures", 
                "description": "Partial seizures with secondary generalization which results in visible clonic or tonic-clonic motor behavior"
            }, 
            {
                "arm_group_label": "Generalized seizures", 
                "description": "Primarily generalized seizures (in patients with either primary [idiopathic] or secondary [symptomatic] generalized epilepsy), which may involve the following depending on the motor manifestation observed: myoclonic seizures, clonic seizures, tonic-clonic seizures, or atonic seizures."
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate patient motion during seizures."
        }, 
        "brief_title": "Epilepsy Motion Sensing", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Epilepsy", 
        "condition_browse": {
            "mesh_term": "Epilepsy"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age or older\n\n          -  Diagnosed with epilepsy and expected to have at least one motor seizure in the EMU\n\n          -  Determined by the Investigator to be an acceptable candidate for epilepsy evaluation\n             with intracranial or scalp electrode monitoring\n\n          -  Willing and able to wear 3 ActiGraph GT3X+ devices for the duration of their\n             participation in the study and comply with the study protocol\n\n          -  Have one of the following seizure types: (a) partial seizures with secondary\n             generalization, which results in visible clonic or tonic-clonic motor behavior; (b)\n             primarily generalized seizures (in patients with either primary [idiopathic] or\n             secondary [symptomatic] generalized epilepsy), which may involve the following\n             depending on the motor manifestation observed:  myoclonic seizures, clonic seizures,\n             tonic-clonic seizures, or atonic seizures.\n\n          -  Be able to consent to participate by signing the Informed Consent document after a\n             full explanation of the nature and purpose of this study\n\n          -  Male or non-pregnant female\n\n          -  English speaking\n\n        Exclusion Criteria:\n\n          -  Currently enrolled in another investigational device, drug, or surgery study.\n             Concurrent physiologic study participation is acceptable\n\n          -  Have an implanted device that may interfere with GT3X+ recordings, ECoG/EEG\n             recordings, ECG recordings, or video recordings\n\n          -  Have a movement disorder that may affect GT3X+ recordings"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with epilepsy referred to epilepsy monitoring unit."
            }
        }, 
        "enrollment": {
            "#text": "19", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850498", 
            "org_study_id": "1663"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Epilepsy", 
            "Seizure", 
            "Motor", 
            "Motion", 
            "Accelerometer"
        ], 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Motion Sensing Study in Epilepsy Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "To identify and evaluate seizure characteristics derived from an accelerometer that can be used in development of a seizure detection algorithm (compared to EEG readings).", 
            "safety_issue": "No", 
            "time_frame": "While patients are being evaluated in an epilepsy monitoring unit."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850498"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Evaluate the accuracy of an accelerometer in identifying seizures (compared to EEG readings).", 
                "safety_issue": "No", 
                "time_frame": "While patients are being evaluated in an epilepsy monitoring unit."
            }, 
            {
                "measure": "Evaluate whether certain seizure types are more capable of being identified by the accelerometer (compared to EEG readings).", 
                "safety_issue": "No", 
                "time_frame": "While patients are being evaluated in an epilepsy monitoring unit."
            }, 
            {
                "measure": "Evaluate heart rate and rhythm changes associated with seizure onset (compared to ECG readings).", 
                "safety_issue": "No", 
                "time_frame": "While patients are being evaluated in an epilepsy monitoring unit."
            }
        ], 
        "source": "MedtronicNeuro", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "MedtronicNeuro", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}